Tech Company Financing Transactions

Capricor Therapeutics Funding Round

Private investors invested in a $10 million funding round for Capricor Therapeutics. The funding round was recorded on 2/4/2015.

Transaction Overview

Announced On
2/4/2015
Transaction Type
Venture Equity
Amount
$10,002,028
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
8840 Wilshire Blvd. 2nd Floor
Beverly Hills, CA 90211
USA
Email Address
Overview
Capricor Therapeutics, Inc. (Nasdaq:CAPR) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of cardiac and other serious medical conditions.
Profile
Capricor Therapeutics LinkedIn Company Profile
Social Media
Capricor Therapeutics Company Twitter Account
Company News
Capricor Therapeutics News
Facebook
Capricor Therapeutics on Facebook
YouTube
Capricor Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Linda Marban
  Linda Marban LinkedIn Profile  Linda Marban Twitter Account  Linda Marban News  Linda Marban on Facebook
Vice President
Luis Martinez
  Luis Martinez LinkedIn Profile  Luis Martinez Twitter Account  Luis Martinez News  Luis Martinez on Facebook
VP - Client Services
Jeffrey Rudy
  Jeffrey Rudy LinkedIn Profile  Jeffrey Rudy Twitter Account  Jeffrey Rudy News  Jeffrey Rudy on Facebook
VP - Finance
AJ Bergmann
  AJ Bergmann LinkedIn Profile  AJ Bergmann Twitter Account  AJ Bergmann News  AJ Bergmann on Facebook
VP - General Counsel
Karen Krasney
  Karen Krasney LinkedIn Profile  Karen Krasney Twitter Account  Karen Krasney News  Karen Krasney on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/4/2015: Crushpath venture capital transaction
Next: 2/4/2015: Catalyst Biosciences venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary